What Do the “Safety Tests” for Stem Cell Conditioned Media Actually Verify? — Dr. Moriwaki Sorts Out the Practical Realities of Lot Management Through Sterility, Mycoplasma, and Endotoxin Testing2026.07.24

“Is conditioned media really safe?” “What is actually inspected in something we inject into the scalp, and how far does that inspection go?” — in the clinical setting of hair regenerative medicine, questions like these from patients have become more frequent. Stem cell conditioned media safety testing is one of the most concrete answers a medical facility can offer to this concern, and it is carried out lot by lot, centered on three pillars: sterility testing, mycoplasma testing, and endotoxin testing. However, just hearing the names of the test items does not convey their meaning, and only by knowing “for what purpose, with what technique, and up to what level of contamination is being ruled out” does the patient acquire the literacy to read a Certificate of Analysis (CoA). This article, from Dr. Moriwaki’s perspective, sorts out what safety testing for conditioned media actually verifies, its limits, and the points patients themselves can check.

Key Points of This Article

・Stem cell conditioned media safety testing is carried out lot by lot across three pillars: sterility, mycoplasma, and endotoxin testing.

・The sterility test verifies contamination by bacteria and fungi, the mycoplasma test verifies contamination by bacteria that are hard to see under a light microscope, and the endotoxin test verifies pyrogens derived from Gram-negative bacteria.

・A verdict of “negative” or “below the limit” does not guarantee zero risk; it must be read with an understanding of the sample volume and detection limit.

・Patients can check for the presence of a Certificate of Analysis (CoA), which laboratory performed the tests, and whether the material is manufactured at a facility registered for specified cell-processed product manufacturing.

・Safety testing is the entrance to quality; it should be read together with potency and composition assessment for a comprehensive quality evaluation.

What Does Stem Cell Conditioned Media Safety Testing Verify?

Stem cell conditioned media is what remains after removing the cellular components from the “secretome” containing growth factors, cytokines, and exosomes that mesenchymal stem cells and similar cells secrete into the culture medium over a defined period. While the cells themselves are not contained, because the raw material is “cultured live cells,” the risk of biological contamination — bacteria, fungi, mycoplasma, viruses, endotoxins — is never zero. That is precisely why conditioned media, as a final product, must be subjected to multiple safety tests on a lot-by-lot basis to ensure the purity and sterility required for administration. In hair regenerative medicine, which presupposes repeated scalp injections, this point cannot be taken lightly.

Sterility Testing — Ruling Out Bacterial and Fungal Contamination

The sterility test inoculates culture media with samples drawn from a lot of conditioned media and, after culturing for a defined period (usually about 14 days), verifies whether bacterial or fungal growth occurs. The Japanese Pharmacopoeia specifies two methods, the “membrane filter method” and the “direct inoculation method,” designed to retain reasonable detection power even with small samples. The judgment is simple: if no growth is seen, the sample is deemed “sterile.” However, the limit of this test is that it can only show “there were no organisms in the sample drawn.” Because the entire lot is not tested, management must be based on the statistical concept of a “sterility assurance level (SAL).” For conditioned media that will be injected into the scalp, lot-by-lot sterility testing is essential to avoid infection risk, and this result should always be recorded on the CoA.

Mycoplasma Testing — The “Hard-to-See Contamination” Lurking in Cell Culture

Mycoplasma is an extremely small bacterium without a cell wall, which is difficult to observe under an ordinary light microscope and is resistant to common antibiotics (such as beta-lactams), making it a representative example of “hard-to-see contamination” in cell culture. The culture medium rarely turns turbid, the cells look almost the same as usual, and it multiplies quietly, which is why it is easy to miss without a dedicated test. Testing methods include agar/broth culture, DNA staining, and PCR, and both the Japanese Pharmacopoeia and the U.S. Pharmacopeia recommend combining multiple methods. When discussing the safety of stem cell conditioned media, whether mycoplasma testing is performed is an important checkpoint: even if the sterility test is negative, if mycoplasma testing has been skipped, the material cannot truly be called “sterile.”

Endotoxin Testing — The “Corpse-Derived Toxin” of Gram-Negative Bacteria

Endotoxin is the lipopolysaccharide (LPS) present in the outer membrane of the cell wall of Gram-negative bacteria; it is difficult to degrade even after the bacteria die, and even small amounts are known to trigger fever, blood pressure drops, and inflammatory reactions. In other words, even if the sterility test is negative, if endotoxin remains as the residue of Gram-negative bacteria that were once present, it may cause a febrile reaction (pyrogen reaction) upon administration. The endotoxin test widely uses the Limulus Amoebocyte Lysate (LAL) assay, derived from the horseshoe crab, in gel clot, turbidimetric, and chromogenic formats. The judgment is made “below the threshold,” which is set considering the route of administration, dose, and body weight. Although scalp injection is a relatively small-volume administration, in regenerative medicine involving repeated procedures cumulative endotoxin exposure cannot be ignored, so strict lot-by-lot management is required.

Quality Evaluation Perspectives That Cannot Be Discussed with Safety Testing Alone

Clearing the three pillars — sterility, mycoplasma, and endotoxin testing — means that the conditioned media is “unlikely to cause acute infection or fever upon administration,” but this alone does not guarantee that it “works.” Safety is the entrance to quality; only when combined with efficacy-side indicators such as potency (amount of growth factors and exosomes), compositional consistency, and storage stability does it become a comprehensive quality evaluation. Please also see the list of related columns on hair regenerative medicine here.

The Certificate of Analysis (CoA) and Test Item Correspondence

The Certificate of Analysis (CoA) is a document that consolidates onto one sheet the test items, specification values, and judgment results performed for that lot. Whether the three items — sterility, mycoplasma, and endotoxin — are included, whether specification values and measured values are listed side by side, and whether the judgment column reads “conforming” — checking these three points alone reveals a great deal about the transparency of lot management. Conversely, if no CoA is provided, or if the test items are vague, then material for objectively evaluating the quality of that conditioned media is scant. For safety information in the dermatology field, the guidelines of the Japanese Dermatological Association may also serve as a reference.

Manufacturing Facility Registration and Traceability

Providing regenerative medicine that administers stem cell conditioned media within Japan requires notification under the Act on the Safety of Regenerative Medicine, and the manufacture of the conditioned media itself also requires notification as a “specified cell-processed product manufacturing facility.” Lots produced at notified facilities should be managed with traceability from donor cell information through culture conditions to final inspection results, which is the foundation underlying the credibility of stem cell conditioned media safety testing. Notification information can be checked on the public database of the Ministry of Health, Labour and Welfare, and it is worth remembering that patients themselves can perform a certain degree of independent verification.

Four Points Patients Can Check for Themselves

Not every patient needs to understand the details of stem cell conditioned media safety testing, but knowing “what to ask” at the moment of choice makes a big difference. Concretely, if you can ask (1) whether you can see the CoA for the lot in question, (2) whether the three items of sterility, mycoplasma, and endotoxin testing are clearly listed, (3) whether the tests were performed by a third-party institution or in-house, and (4) whether the manufacturing facility is a notified specified cell-processed product manufacturer — this level of questioning is practically sufficient as safety literacy for conditioned media. If only vague answers such as “I don’t know the details” or “our product is fine” come back, then pausing before rushing into treatment is a reasonable judgment. Because indications differ with individual variation, constitution, and treatment site conditions, please consult with us in advance.

Frequently Asked Questions

Q. If the sterility test is negative, is it 100% safe?

A “negative” sterility test means that bacterial or fungal growth was not detected in the sample drawn from the lot; it does not guarantee zero risk for the entire lot. Management is based on the statistical concept of a sterility assurance level (SAL), and other contamination indicators such as mycoplasma and endotoxin must also be evaluated together.

Q. Should I avoid conditioned media for which mycoplasma testing has been omitted?

Ideally, we recommend choosing lots where all three pillars have been performed. Because mycoplasma is difficult to detect in ordinary sterility testing, without a dedicated test being performed, the possibility of “hard-to-see contamination” cannot be ruled out. Checking with the CoA is the most reliable approach.

Q. What kind of effects does endotoxin cause?

Endotoxin is a lipopolysaccharide derived from Gram-negative bacteria, and even in small amounts it can cause fever and inflammatory reactions. Scalp injection is a small-volume administration, but in regenerative medicine involving repeated sessions, cumulative exposure cannot be ignored, so management below the threshold on a lot-by-lot basis is important.

Q. Can anyone ask to see the Certificate of Analysis (CoA)?

Many medical institutions can present it upon patient request. If they are reluctant to show it, or if the answer is “such a thing does not exist,” it is safer to assume that the quality transparency of that lot is not assured.

Q. If it passes the safety tests, can I also expect it to be effective?

Safety testing ensures that “harm is unlikely to result from administration” and is on a different axis from efficacy. Effect is determined by multiple factors including the amount and activity of growth factors and exosomes, the administration protocol, and the patient’s own hair follicle state, so safety and efficacy must be read as separate indicators.

──────────────

Supervising physician: Shin Moriwaki, MD

Member, Japan Society of Aesthetic Surgery (JSAS)

Member, American Academy of Aesthetic Medicine

ECFMG Certificate

──────────────

📍AVAN TOKYO 銀座 毛髪再生医療

AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt available

Inquiries welcome via DM / LINE / Website / Phone.